Frequency Therapeutics Revenue and Competitors

Claim your profile

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • Frequency Therapeutics's estimated annual revenue is currently $24M per year.(i)
  • Frequency Therapeutics received $42.0M in venture funding in January 2019.
  • Frequency Therapeutics's estimated revenue per employee is $407,119
  • Frequency Therapeutics's total funding is $180.3M.
  • Frequency Therapeutics's current valuation is $177.9M. (January 2022)

Employee Data

  • Frequency Therapeutics has 59 Employees.(i)
  • Frequency Therapeutics grew their employee count by -30% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Frequency Therapeutics News

2022-04-13 - Frequency Therapeutics Inc (FREQ) Stock Increases 29.29% This Week; Should You Buy?

Frequency Therapeutics Inc (FREQ) stock is lower by -80.79% over the last 12 months, and the average rating from Wall Street analysts is a...

2022-04-06 - MIT scientists have managed to reverse hearing loss with new ...

Frequency Therapeutics, the biotechnology company responsible for the new treatment, was founded in part by scientists from MIT.

2022-03-22 - Reversing hearing loss with regenerative therapy | MIT News ...

The biotechnology company Frequency Therapeutics is seeking to reverse hearing loss — not with hearing aids or implants, but with a new kind...

2019-09-08 - Frequency Plans IPO for Hearing Loss Drug & More ...

Hearing loss affects millions of Americans but to date, there are no FDA-approved medicines to treat them. Frequency Therapeutics is ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Frequency Therapeutics Funding

DateAmountRoundLead InvestorsReference
2017-04-12$32.0MACoBro VenturesArticle
2019-01-08$42.0MBTaiwania Capital ManagementArticle